Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis
Crossref DOI link: https://doi.org/10.1007/s10238-016-0420-7
Published Online: 2016-04-19
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yue-Meng, Wan
Li, Yu-Hua
Wu, Hua-Mei
Yang, Jing
Xu, Ying
Yang, Li-Hong
Yang, Jin-Hui
Text and Data Mining valid from 2016-04-19